Abstract
No public abstract is available from the verified source records.
Michele Marinò, Elena Sabini
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Graves' disease-associated dopaminergic system dysfunction and its effects on striatocortical functional connectivity and cognitive function
2025
Graves' disease and bone mineral density: A scoping review of the impact of graves' disease on spinal health
10.1016/j.jocd.2025.101621 · 2025
Long-Term treatment of hyperthyroidism with antithyroid drugs: 35 years of personal clinical experience
10.1089/thy.2019.0814 · 2020
Diagnosis and management of graves disease: A global overview
10.1038/nrendo.2013.193 · 2013
Extrathyroidal manifestations of graves' disease: A 2014 update
10.1007/s40618-014-0097-2 · 2014
Cardiovascular involvement in patients with different causes of hyperthyroidism
10.1038/nrendo.2010.105 · 2010
Older subjects with hyperthyroidism present with a paucity of symptoms and signs: A large cross-sectional study
10.1210/jc.2009-2495 · 2010
Anxiety and depression are more prevalent in patients with graves' disease than in patients with nodular goitre
10.1159/000365211 · 2014
Evidence for a major role of heredity in graves' disease: A population-based study of two danish twin cohorts
2001
Thyroid disease and mental disorders: Cause and effect or only comorbidity?
10.1097/yco.0b013e3283387b50 · 2010
Expression of erbA alpha and beta mRNAs in regions of adult rat brain
10.1016/0303-7207(90)90054-c · 1990
Effects of GH replacement therapy on thyroid volume and nodule development in GH deficient adults: A retrospective cohort study
10.1530/eje-14-0966 · 2015
Acute cardiovascular events and all-cause mortality in patients with hyperthyroidism: A population-based cohort study
10.1530/eje-16-0576 · 2017
Increased generation of fibrocytes in thyroid-associated ophthalmopathy
10.1210/jc.2009-1614 · 2010
B cells from patients with graves' disease aberrantly express the IGF-1 receptor: Implications for disease pathogenesis
10.4049/jimmunol.181.8.5768 · 2008
Hyperthyroidism in the elderly. I. Clinical manifestations
1985
The cells of the human adenohypophysis in thyroid disorders
10.1210/jcem-19-8-958 · 1959
Thyroid acropachy: Report of 40 patients treated at a single institution in a 26-year period
10.1210/jc.2002-020746 · 2002
Human fibrocytes coexpress thyroglobulin and thyrotropin receptor
2012
Skeletal changes associated with hyperthyroidism
1953
Graves' disease and mental disorders
10.1016/j.jcte.2019.100207 · 2020
Immunological drivers in graves' disease: NK cells as a master switcher
10.3389/fendo.2020.00406 · 2020
Structural insights into brain thyroid hormone transport via MCT8 and OATP1C1
10.1016/j.cell.2025.06.032 · 2025
Environmental exposure during pregnancy: Influence on prenatal development and early life: A comprehensive review
10.1159/000514884 · 2021
Effect of hypo- and hyperthyroidism on gastric myoelectrical activity
10.1023/a:1022876423487 · 2003
A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis
10.1056/nejmoa2309000 · 2024
Structural brain changes in hyperthyroid graves' disease: Protocol for an ongoing longitudinal, case-controlled study in Göteborg, Sweden-the CogThy project
10.1136/bmjopen-2019-031168 · 2019
Comprehensive study of urinary cortisol metabolites in hyperthyroid and hypothyroid patients
10.1111/j.1365-2265.2005.02412.x · 2006
Management of graves thyroidal and extrathyroidal disease: An update
10.1210/clinem/dgaa646 · 2020
Bone mineral density in hyperthyroidism
10.1111/j.1365-2265.2004.02110.x · 2004
Disturbances of menstruation in thyroid disease
10.1111/j.1749-6632.1997.tb52152.x · 1997
Bidirectional TSH and IGF-1 receptor cross talk mediates stimulation of hyaluronan secretion by graves' disease immunoglobins
10.1210/jc.2014-3566 · 2015
Insulin sensitivity and beta-cell function in graves' disease and their changes with the carbimazole-induced euthyroid state
10.1159/000496924 · 2019
Graves disease: Latest understanding of pathogenesis and treatment options
10.1038/s41574-024-01016-5 · 2024
Hyperthyroidism: A review
10.1001/jama.2023.19052 · 2023
Excess mortality in treated and untreated hyperthyroidism is related to cumulative periods of low serum TSH
10.1210/jc.2017-00166 · 2017
Epigenetic profiling in CD4+ and CD8+ T cells from graves' disease patients reveals changes in genes associated with T cell receptor signaling
10.1016/j.jaut.2015.09.006 · 2016
Muscle performance and postural stability are reduced in patients with newly diagnosed graves' disease
10.1089/thy.2018.0318 · 2019
Outcomes of patients with graves disease 25 years after initiating antithyroid drug therapy
10.1210/clinem/dgad538 · 2024
Long-term prognosis after medical treatment of graves' disease in a northern Swedish population 2000-2010
10.1530/eje-13-0811 · 2014
Grey matter abnormalities in untreated hyperthyroidism: A voxel-based morphometry study using the DARTEL approach
10.1016/j.ejrad.2013.09.019 · doi-reference
The influence of hyperthyroidism on the hypothalamic-pituitary-gonadal axis
10.1055/s-2000-7756 · doi-reference
Thyroid eye disease (graves' orbitopathy): Clinical presentation, epidemiology, pathogenesis, and management
10.1016/s2213-8587(25)00066-x · doi-reference
Graves' disease
10.1056/nejm200010263431707 · doi-reference
Predicting the risk of recurrence before the start of antithyroid drug therapy in patients with graves' hyperthyroidism
10.1210/jc.2015-3644 · doi-reference
Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: A tale of two antigens implicated in graves' disease
10.4049/jimmunol.181.6.4397 · doi-reference
Mechanisms of autoimmune thyroid diseases: From genetics to epigenetics
10.1146/annurev-pathol-012513-104713 · doi-reference
Global epidemiology of hyperthyroidism and hypothyroidism
10.1038/nrendo.2018.18 · doi-reference
The association of overt and subclinical hyperthyroidism with the risk of cardiovascular events and cardiovascular mortality: Meta-analysis and systematic review of cohort studies
10.3803/enm.2020.728 · doi-reference
Graves' disease
10.1056/nejmra1510030 · doi-reference
Thyroid eye disease and the IGF-1 receptor
10.1016/s2213-8587(25)00218-9 · doi-reference
Secretory dynamics of growth hormone in an acromegalic patient associated with graves' disease
10.1210/jcem-71-4-1059 · doi-reference
Risk factors for the relapse of graves' disease treated with antithyroid drugs: A systematic review and meta-analysis
10.1016/j.clinthera.2020.01.022 · doi-reference
The pituitary gland in hyperthyroidism
10.1016/s0025-6196(12)60272-9 · doi-reference
Transplacental passage of anti-thyroid auto-antibodies in a pregnant woman with auto-immune thyroid disease
10.1002/(sici)1097-0223(199905)19:5<468::aid-pd540>3.0.co;2-# · doi-reference
Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with graves' disease is mediated through the insulin-like growth factor I receptor pathway
10.4049/jimmunol.170.12.6348 · doi-reference
Primary therapy of graves' disease and cardiovascular morbidity and mortality: A linked-record cohort study
10.1016/s2213-8587(19)30059-2 · doi-reference
Graves' disease. Influence of age on clinical findings
10.1001/archinte.1988.00380030132023 · doi-reference
Thyrotoropin receptor knockout changes monoaminergic neuronal system and produces methylphenidate-sensitive emotional and cognitive dysfunction
10.1016/j.psyneuen.2014.05.021 · doi-reference
Immuno-localisation of anti-thyroid antibodies in adult human cerebral cortex
10.1016/j.jns.2010.11.027 · doi-reference
Long-term prognosis after medical treatment of graves' disease in a northern Swedish population 2000-2010
10.1530/eje-13-0811 · doi-reference
Outcomes of patients with graves disease 25 years after initiating antithyroid drug therapy
10.1210/clinem/dgad538 · doi-reference
Muscle performance and postural stability are reduced in patients with newly diagnosed graves' disease
10.1089/thy.2018.0318 · doi-reference
Epigenetic profiling in CD4+ and CD8+ T cells from graves' disease patients reveals changes in genes associated with T cell receptor signaling
10.1016/j.jaut.2015.09.006 · doi-reference
Excess mortality in treated and untreated hyperthyroidism is related to cumulative periods of low serum TSH
10.1210/jc.2017-00166 · doi-reference
Graves disease: Latest understanding of pathogenesis and treatment options
10.1038/s41574-024-01016-5 · doi-reference
Insulin sensitivity and beta-cell function in graves' disease and their changes with the carbimazole-induced euthyroid state
10.1159/000496924 · doi-reference
Bidirectional TSH and IGF-1 receptor cross talk mediates stimulation of hyaluronan secretion by graves' disease immunoglobins
10.1210/jc.2014-3566 · doi-reference
Disturbances of menstruation in thyroid disease
10.1111/j.1749-6632.1997.tb52152.x · doi-reference
Bone mineral density in hyperthyroidism
10.1111/j.1365-2265.2004.02110.x · doi-reference
Management of graves thyroidal and extrathyroidal disease: An update
10.1210/clinem/dgaa646 · doi-reference
Comprehensive study of urinary cortisol metabolites in hyperthyroid and hypothyroid patients
10.1111/j.1365-2265.2005.02412.x · doi-reference
Structural brain changes in hyperthyroid graves' disease: Protocol for an ongoing longitudinal, case-controlled study in Göteborg, Sweden-the CogThy project
10.1136/bmjopen-2019-031168 · doi-reference
A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis
10.1056/nejmoa2309000 · doi-reference
Effect of hypo- and hyperthyroidism on gastric myoelectrical activity
10.1023/a:1022876423487 · doi-reference
Environmental exposure during pregnancy: Influence on prenatal development and early life: A comprehensive review
10.1159/000514884 · doi-reference
Structural insights into brain thyroid hormone transport via MCT8 and OATP1C1
10.1016/j.cell.2025.06.032 · doi-reference
Immunological drivers in graves' disease: NK cells as a master switcher
10.3389/fendo.2020.00406 · doi-reference
Graves' disease and mental disorders
10.1016/j.jcte.2019.100207 · doi-reference
Thyroid acropachy: Report of 40 patients treated at a single institution in a 26-year period
10.1210/jc.2002-020746 · doi-reference